6OKV | pdb_00006okv

PilT4 from Geobacter metallireducens bound to AMP-PNP: C2ccocco conformation


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 4.01 Å
  • R-Value Free: 
    0.280 (Depositor), 0.280 (DCC) 
  • R-Value Work: 
    0.243 (Depositor), 0.246 (DCC) 
  • R-Value Observed: 
    0.245 (Depositor) 

Starting Model: experimental
View more details

wwPDB Validation 3D Report Full Report

Validation slider image for 6OKV

Ligand Structure Quality Assessment 


This is version 1.3 of the entry. See complete history

Literature

Multiple conformations facilitate PilT function in the type IV pilus.

McCallum, M.Benlekbir, S.Nguyen, S.Tammam, S.Rubinstein, J.L.Burrows, L.L.Howell, P.L.

(2019) Nat Commun 10: 5198-5198

  • DOI: https://doi.org/10.1038/s41467-019-13070-z
  • Primary Citation Related Structures: 
    6OJX, 6OJY, 6OJZ, 6OK2, 6OKV, 6OLJ, 6OLK, 6OLL, 6OLM

  • PubMed Abstract: 

    Type IV pilus-like systems are protein complexes that polymerize pilin fibres. They are critical for virulence in many bacterial pathogens. Pilin polymerization and depolymerization are powered by motor ATPases of the PilT/VirB11-like family. This family is thought to operate with C 2 symmetry; however, most of these ATPases crystallize with either C 3 or C 6 symmetric conformations. The relevance of these conformations is unclear. Here, we determine the X-ray structures of PilT in four unique conformations and use these structures to classify the conformation of available PilT/VirB11-like family member structures. Single particle electron cryomicroscopy (cryoEM) structures of PilT reveal condition-dependent preferences for C 2, C 3 , and C 6 conformations. The physiologic importance of these conformations is validated by coevolution analysis and functional studies of point mutants, identifying a rare gain-of-function mutation that favours the C 2 conformation. With these data, we propose a comprehensive model of PilT function with broad implications for PilT/VirB11-like family members.


  • Organizational Affiliation
    • Department of Biochemistry, University of Toronto, Toronto, ON, M5S 1A8, Canada.

Macromolecule Content 

  • Total Structure Weight: 260.28 kDa 
  • Atom Count: 16,189 
  • Modeled Residue Count: 2,117 
  • Deposited Residue Count: 2,310 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
Twitching motility pilus retraction ATPase
A, B, C, D, E
A, B, C, D, E, F
385Geobacter metallireducens GS-15Mutation(s): 0 
Gene Names: pilT-4Gmet_1394
UniProt
Find proteins for Q39VU6 (Geobacter metallireducens (strain ATCC 53774 / DSM 7210 / GS-15))
Explore Q39VU6 
Go to UniProtKB:  Q39VU6
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupQ39VU6
Sequence Annotations
Expand
Reference Sequence

Small Molecules

Ligands 3 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
ANP

Query on ANP



Download:Ideal Coordinates CCD File
H [auth A],
J [auth B],
M [auth D],
O [auth E]
PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER
C10 H17 N6 O12 P3
PVKSNHVPLWYQGJ-KQYNXXCUSA-N
ADP

Query on ADP



Download:Ideal Coordinates CCD File
K [auth C],
P [auth F]
ADENOSINE-5'-DIPHOSPHATE
C10 H15 N5 O10 P2
XTWYTFMLZFPYCI-KQYNXXCUSA-N
MG

Query on MG



Download:Ideal Coordinates CCD File
G [auth A],
I [auth B],
L [auth D],
N [auth E]
MAGNESIUM ION
Mg
JLVVSXFLKOJNIY-UHFFFAOYSA-N

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 4.01 Å
  • R-Value Free:  0.280 (Depositor), 0.280 (DCC) 
  • R-Value Work:  0.243 (Depositor), 0.246 (DCC) 
  • R-Value Observed: 0.245 (Depositor) 
Space Group: P 21 21 21
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 98.51α = 90
b = 127.13β = 90
c = 187.26γ = 90
Software Package:
Software NamePurpose
PHENIXrefinement
XDSdata reduction
XDSdata scaling
PHASERphasing

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

& Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
Canadian Institutes of Health Research (CIHR)Canada--

Revision History  (Full details and data files)

  • Version 1.0: 2019-11-20
    Type: Initial release
  • Version 1.1: 2019-11-27
    Changes: Database references
  • Version 1.2: 2020-01-08
    Changes: Author supporting evidence
  • Version 1.3: 2023-10-11
    Changes: Data collection, Database references, Derived calculations, Refinement description